Pioneers in research that has lead to better health and medicine world-wide, Weizmann has a long list of achievements. Some include the discovery of the basis of amniocentesis and new fertility treatments; the founding of two leading treatments for Multiple Sclerosis (MS) called Copaxone® and Rebif®; and the development of advanced image scanning technology. Currently under development are vaccines for flu and diabetes; growing new organs and T cells to treat damaged spines from stem cells; and finding out how diseases originated. Discovering how medicine and therapies will evolve is also a key focus: personalised medicine that provides treatments and therapies based on the individual’s genetic make-up are the future, and Weizmann’s new Nancy and Stephen Grand Israel National Center for Personalized Medicine is working hard to make this a reality. In Australia, Weizmann collaborations with leading universities have also played a role in understanding the basis of disease in a bid to develop better treatments and help our world to become a healthier place. Weizmann has recently joined forces with Australia’s famous Garvan Institute of Medical Research to establish the Garvan-Weizmann Centre for Cellular Genomics where these two great research centres will create synergistic research platforms to advance cellular genomic science.